UBS Group AG - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 34 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$10,053
+37.7%
10,000
+42.9%
0.00%
Q1 2023$7,301
-99.0%
7,0000.0%0.00%
Q4 2022$752,220
+12437.0%
7,000
+16.7%
0.00%
Q3 2022$6,000
-25.0%
6,000
-25.0%
0.00%
Q2 2022$8,000
-20.0%
8,000
-20.0%
0.00%
Q1 2022$10,000
-16.7%
10,000
-16.7%
0.00%
Q4 2021$12,000
-25.0%
12,000
-25.0%
0.00%
Q3 2021$16,0000.0%16,0000.0%0.00%
Q2 2021$16,00016,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
Wellesley Asset Management 55,306,226$54,866,5182.72%
MACKAY SHIELDS LLC 76,286,000$74,883,9012.06%
Sonora Investment Management Group, LLC 10,890,000$10,840,0750.93%
ADVENT CAPITAL MANAGEMENT /DE/ 39,812,000$39,636,8270.92%
BANQUE PICTET & CIE SA 636,000$63,228,5450.75%
PIER 88 INVESTMENT PARTNERS LLC 1,902,000$1,884,6160.47%
LOOMIS SAYLES & CO L P 2,074,551$183,5570.32%
Liberty Mutual Group Asset Management Inc. 1,025,000$1,0150.28%
iA Global Asset Management Inc. 14,690,000$14,6250.24%
RATIONAL ADVISORS LLC 1,803,000$1,786,0520.16%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders